Encoded Therapeutics
Nick Williams has extensive experience in finance, with their most recent role being Head of Finance at Encoded Therapeutics Inc. Nick previously held positions as Vice President Finance at Dermira, Inc., Director of Finance at InterMune, Sr Manager Commercial Finance at Onyx Pharmaceuticals, Inc., and Sr Manager R&D Finance and Finance Manager - Commercial Finance at Amgen. Nick also worked as a Sr Financial Analyst - Commercial Finance at Amgen, a Financial Analyst at Karl Storz Endoskope, and a Financial Analyst at Procter & Gamble. Nick'swork experience spans from 2003 to the present.
Nick Williams attended the Pepperdine Graziadio Business School, where they earned a Master of Business Administration (MBA) degree. Nick also attended North Carolina Agricultural and Technical State University, but it is unclear if they obtained a degree or studied a specific field.
Encoded Therapeutics
1 followers
Encoded leverage the power of the human genome to deliver highly effective precision therapies, leading to life-changing and lasting benefits for individuals with genetic disorders.